1. Home
  2. GLRE vs TOI Comparison

GLRE vs TOI Comparison

Compare GLRE & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlight Capital Re Ltd.

GLRE

Greenlight Capital Re Ltd.

HOLD

Current Price

$15.52

Market Cap

554.9M

Sector

Finance

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$5.13

Market Cap

497.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLRE
TOI
Founded
2004
2007
Country
Cayman Islands
United States
Employees
N/A
641
Industry
Property-Casualty Insurers
Medical/Nursing Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
554.9M
497.9M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
GLRE
TOI
Price
$15.52
$5.13
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
147.0K
1.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
75.00
N/A
EPS
0.18
N/A
Revenue
$729,777,000.00
N/A
Revenue This Year
N/A
$30.15
Revenue Next Year
N/A
$25.77
P/E Ratio
$86.89
N/A
Revenue Growth
4.85
N/A
52 Week Low
$11.57
$2.32
52 Week High
$19.39
$6.67

Technical Indicators

Market Signals
Indicator
GLRE
TOI
Relative Strength Index (RSI) 38.57 48.50
Support Level $14.78 $4.90
Resistance Level $17.05 $5.63
Average True Range (ATR) 0.57 0.37
MACD -0.15 -0.08
Stochastic Oscillator 32.88 26.71

Price Performance

Historical Comparison
GLRE
TOI

About GLRE Greenlight Capital Re Ltd.

Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: